# Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

> **NCT02296164** · — · COMPLETED · sponsor: **Helsinn Therapeutics (U.S.), Inc** · enrollment: 300 (actual)

## Conditions studied

- Mycosis Fungoides

## Interventions

- **DRUG:** Valchlor

## Key facts

- **NCT ID:** NCT02296164
- **Lead sponsor:** Helsinn Therapeutics (U.S.), Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-12
- **Primary completion:** 2018-10-17
- **Final completion:** 2018-10-17
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296164, "Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02296164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*